Neuroscience
Parkinson's Disease
100%
Positron Emission Tomography
65%
Positron Emission Tomography
64%
Fluorine-18
42%
Dopaminergic
25%
Alzheimer's Disease
24%
In Vivo
23%
Putamen
22%
Amyloid
18%
Magnetic Resonance Imaging
13%
Parkinsonism
13%
L-DOPA
13%
Mild Cognitive Impairment
11%
Flumazenil
10%
Basal Ganglia
9%
Tremor
9%
Striatum
9%
Raclopride
9%
Huntington's Disease
8%
Receptor Binding
8%
Dyskinesia
8%
Metabolic Pathway
7%
Microglia
7%
Functional Imaging
7%
Gray Matter
7%
Multiple System Atrophy
6%
Cerebellum
6%
Diprenorphine
6%
Cognitive Disorders
6%
Stereotypic Movement Disorder
6%
Thalamus
6%
Statistical Parametric Mapping
6%
Frontal Lobe
5%
δ -Opioid Receptor
5%
Single-Photon Emission Computed Tomography
5%
Dopamine Release
5%
Progressive Supranuclear Palsy
5%
Dementia with Lewy Bodies
5%
Benzodiazepine Receptor
5%
Rapid Eye Movement Sleep Behavior Disorder
5%
Medicine and Dentistry
Parkinson's Disease
27%
Positron Emission Tomography
23%
Positron Emission Tomography
16%
Amyloid
13%
Alzheimer's Disease
12%
Fluorine-18
11%
Carbon 11
8%
Putamen
6%
Parkinsonism
6%
Magnetic Resonance Imaging
5%
Biological Marker
5%
Mild Cognitive Impairment
5%
